Document is current
Any future updates will be listed below
-
Authors
Wang, Linxiao
Liu, Shanshou
Wang, Xianqi
Wu, Huirong
Zhao, Xiaojun
Wu, Dan
Wang, Qianmei
Wang, Peiwen
Xu, Yanan
Shen, Kuo
Yuan, Juzheng
Li, Junjie
-
Funding
Funding for this research was provided by:
the Key Research and Development Program of Shaanxi Province (2025JC-YBQN-1295)
the Key Research and Development Program of Shaanxi Province (2025JC-QYCX-083)
Youth Science Fund Project (82502995)
the National Natural Science Foundation of China (82572467)
- License Information
-
More Information
Article History
Received: 26 January 2026
Accepted: 29 March 2026
First Online: 11 April 2026
Declarations
:
: Approval for the study was obtained from the relevant ethics committee, and informed consent was secured from all participants. The study protocols involving human samples were approved by the Ethics Committee of Xijing Hospital (Approval No. KY20212172-C-1, 2021;KY2023319-1, 2023). All animal experiments were conducted in compliance with the protocols approved by the Experimental Animal Committee of Fourth Military Medical University (Inhibitory effect of ADAR1 on macrophage exosomal miR-122 in improving myocardial injury in sepsis and its mechanism, Approval No. IACUC-2024002, 2024).
: All the authors approved the submission of the manuscript to this journal.
: The authors declare no competing interests.
